AGBIO Diagnostics Overview

  • Founded
  • 1994
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 1

AGBIO Diagnostics General Information


Developer of DNA micro array technology designed to diagnose infectious diseases. The company's development efforts focuses in the area of enteric virus, drug resistance of tubercular bacillus and sexual transmitted disease diagnosis, enabling researchers to find a cost-effective treatment.

Contact Information

Formerly Known As
Biomedlab Co
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Primary Office
  • Number 901, 551-17, Yangcheon-ro
  • Gangseo-gu
  • Seoul
  • South Korea
+82 00-000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AGBIO Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC Completed Generating Revenue
To view AGBIO Diagnostics’s complete valuation and funding history, request access »

AGBIO Diagnostics Executive Team (1)

Name Title Board Seat Contact Info
Back Chul Chief Executive Officer
To view AGBIO Diagnostics’s complete executive team members history, request access »

AGBIO Diagnostics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Korea Investment Partners Venture Capital Minority 000 0000 000000 0
To view AGBIO Diagnostics’s complete investors history, request access »